Efficacy and Safety of Trastuzumab Deruxtecan (T-DXd) in HER2-Mutated Advanced Metastatic Non-Small Cell Lung Cancer: A Meta-Analysis of Clinical Trials

Authors

• Nitya Batra
• Yagnapriya Ammakola, Corewell Health East Resident
• Rahul Mishra
• Mahnoor Sukaina
• Atulya Aman Khosla, Corewell Health East Resident
• Tulika Garg
• Akshit Chitkara
• Rohit Singh
• Yajur Arya
• Arshi Syal
• Himil Mahadevia
• Karan Jatwani

Document Type

Conference Proceeding

Publication Date

5-2026

Publication Title

Journal of Thoracic Oncology

Volume

21

Issue

5 Suppl 1

First Page

103793

Comments

IASLC / ASCO North American Conference on Lung Cancer, December 5-7, 2026, Chicago, IL

Last Page

103793

Recommended Citation

Batra N, Ammakola Y, Mishra R, Sukaina M, Khosla AA, Garg T, et al. Efficacy and safety of trastuzumab deruxtecan (T-DXd) in HER2-mutated advanced metastatic non-small cell lung cancer: a meta-analysis of clinical trials. J Thorac Oncol. 2026 May;21(5 Suppl 1):103793. doi:10.1016/j.jtho.2026.103793

DOI

10.1016/j.jtho.2026.103793